IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
0.830
-0.015 (-1.78%)
At close: Jul 19, 2024, 4:00 PM
0.835
+0.005 (0.60%)
Pre-market: Jul 22, 2024, 6:13 AM EDT
IN8bio Employees
IN8bio had 31 employees as of December 31, 2023. The number of employees increased by 5 or 19.23% compared to the previous year.
Employees
31
Change (1Y)
5
Growth (1Y)
19.23%
Revenue / Employee
n/a
Profits / Employee
-$1,001,419
Market Cap
36.62M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 31 | 5 | 19.23% |
Dec 31, 2022 | 26 | 7 | 36.84% |
Dec 31, 2021 | 19 | 12 | 171.43% |
Sep 30, 2020 | 7 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
DarioHealth | 294 |
Aadi Bioscience | 89 |
Precision Optics Corporation | 85 |
IceCure Medical | 77 |
Xilio Therapeutics | 73 |
Aligos Therapeutics | 66 |
Cue Biopharma | 53 |
INAB News
- 27 days ago - IN8bio to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire
- 5 weeks ago - IN8bio Presents Positive Data Demonstrating Durable 1-year Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 - GlobeNewsWire
- 7 weeks ago - IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 2 months ago - IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024 - GlobeNewsWire
- 2 months ago - IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual Meeting - GlobeNewsWire
- 2 months ago - IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress - GlobeNewsWire
- 2 months ago - IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 - GlobeNewsWire
- 2 months ago - IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire